Serious adverse events · people with fatigue in peripheral neuropathy
Ascorbic acid showed no clear difference in serious adverse events compared with placebo (moderate certainty).
1 finding from 1 review
Serious adverse events · people with fatigue in Guillain‐Barré syndrome
1 finding from 1 review
no estimate extracted
80 participants
GRADE not reported
Serious adverse events · Children and adolescents with femoral shaft fractures
Surgical interventions may leads to higher serious adverse events compared with conservative interventions (low certainty).
1 finding from 1 review
Intervention not reported
Serious adverse events · adults with acute pain
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Serious adverse events · critically ill patients or receiving major surgery
Glutamine‐supplemented nutrition showed no clear difference in serious adverse events compared with non‐supplemented nutrition (moderate certainty).
1 finding from 1 review
Serious adverse events · patients with anaemia
It is very uncertain whether parenteral iron changes serious adverse events compared with inactive control (very low certainty).
1 finding from 1 review
Serious adverse events · patients with anaemia
It is very uncertain whether parenteral iron changes serious adverse events compared with oral iron (very low certainty).
1 finding from 1 review
Serious adverse events · patients with anaemia
It is very uncertain whether oral iron changes serious adverse events compared with inactive control (very low certainty).
1 finding from 1 review
Intervention not reported
Serious adverse events · neuropathic pain (5 studies in painful diabetic neuropathy and polyneuropathy)
1 finding from 1 review
Intervention not reported
Serious adverse events · neuropathic pain (6 studies in central neuropathic pain due to multiple sclerosis, spinal cord injury, polyneuropathy, central post‐stroke…
1 finding from 1 review
Intervention not reported
Serious adverse events · adults with peripheral neuropathic pain conditions
1 finding from 1 review
Intervention not reported
Serious adverse events · adults with neuropathic pain (3 studies in painful diabetic neuropathy and postherpetic neuralgia)
1 finding from 1 review
Intervention not reported
Serious adverse events · adults with complex regional pain syndrome type 1 (lower limb)
1 finding from 1 review
no estimate extracted
20 participants
Very low
Serious adverse events · Children and adults with blood smear positive P. vivax malaria1
1 finding from 1 review
Intervention not reported
Serious adverse events · People with P. vivax malaria1
1 finding from 1 review
Intervention not reported
Serious adverse events · People with P. vivax malaria1
1 finding from 1 review
Serious adverse events · People with P. vivax malaria1
1 finding from 1 review
Serious adverse events · People with P. vivax malaria1
1 finding from 1 review
Intervention not reported
Serious adverse events · participants with rheumatoid arthritis and with partial response to MTX
The intervention showed no clear difference in serious adverse events (moderate certainty).
1 finding from 1 review
Intervention not reported
Serious adverse events · participants with rheumatoid arthritis and with a partial response to DMARDs
The intervention showed no clear difference in serious adverse events (moderate certainty).
1 finding from 1 review